Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacologic Characterization of LTGO-33, a Selective Small Molecule Inhibitor of the Voltage-Gated Sodium Channel NaV1.8 with a Unique Mechanism of Action
John M. Gilchrist, Nien-Du Yang, Victoria Jiang, et al.
Molecular Pharmacology (2024) Vol. 105, Iss. 3, pp. 233-249
Open Access | Times Cited: 13

Showing 13 citing articles:

Pharmacology and Mechanism of Action of Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain
Jeremiah D. Osteen, Swapna Immani, Tim L. Tapley, et al.
Pain and Therapy (2025)
Open Access | Times Cited: 6
Voltage-gated sodium channels in excitable cells as drug targets
Matthew Alsaloum, Sulayman D. Dib‐Hajj, Dana A. Page, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 3
State-dependent inhibition of Nav1.8 channels by VX-150 and VX-548
Patric Vaelli, Akie Fujita, Sooyeon Jo, et al.
Molecular Pharmacology (2024) Vol. 106, Iss. 6, pp. 298-308
Closed Access | Times Cited: 6
Targeted ubiquitination of NaV1.8 reduces sensory neuronal excitability
Sidharth Tyagi, Mohammad‐Reza Ghovanloo, Matthew Alsaloum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Humanized NaV1.8 rats overcome cross-species potency shifts in developing novel NaV1.8 inhibitors
Dillon S. McDevitt, Joshua D. Vardigan, Xiaoping Zhou, et al.
Neurobiology of Pain (2025), pp. 100182-100182
Open Access
In Vitro Inhibition of Voltage-Dependent Sodium Currents by the Antifungal Drug Amorolfine
Mohammad‐Reza Ghovanloo, Sidharth Tyagi, Philip R. Effraim, et al.
Journal of Biological Chemistry (2025), pp. 108407-108407
Open Access
Differential state-dependent Nav1.8 inhibition by suzetrigine, LTGO-33, and A-887826
Sooyeon Jo, Akie Fujita, Tomás Osorno, et al.
The Journal of General Physiology (2025) Vol. 157, Iss. 4
Closed Access
Vers une nouvelle génération d’antidouleurs
Marla Broadfoot
Pour la Science (2025) Vol. nº 570, Iss. 4, pp. 46-55
Closed Access
Interplay of Nav1.8 and Nav1.7 channels drives neuronal hyperexcitability in neuropathic pain
Dmytro V. Vasylyev, Peng Zhao, Betsy R. Schulman, et al.
The Journal of General Physiology (2024) Vol. 156, Iss. 11
Closed Access | Times Cited: 3
Insights into the voltage-gated sodium channel, NaV1.8, and its role in visceral pain perception
J Westley Heinle, Shannon Dalessio, Piotr Janicki, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Carbamazepine in osteoarthritis treatment: A novel approach targeting Nav1.7 channels
Rayyan Vaid, Afra Sohail, Nabiha Amir
World Journal of Orthopedics (2024) Vol. 15, Iss. 6, pp. 602-604
Open Access | Times Cited: 1
Harnessing Deep Learning Methods for Voltage-Gated Ion Channel Drug Discovery
Diego López Mateos, B. Harris, Adriana Hernández González, et al.
Physiology (2024) Vol. 40, Iss. 1, pp. 67-87
Closed Access
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential
Huan Wang, Jian Huang, Jie Zang, et al.
Current Opinion in Chemical Biology (2024) Vol. 83, pp. 102538-102538
Closed Access
Development and characterization of pyridyl carboxamides as potent and highly selective Nav1.8 inhibitors
Michael S. Poslusney, Glen Ernst, Yifang Huang, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 117, pp. 130059-130059
Closed Access
Page 1

Scroll to top